Margot Zevon

1.0k total citations · 1 hit paper
8 papers, 871 citations indexed

About

Margot Zevon is a scholar working on Biomedical Engineering, Pulmonary and Respiratory Medicine and Biomaterials. According to data from OpenAlex, Margot Zevon has authored 8 papers receiving a total of 871 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Biomedical Engineering, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Biomaterials. Recurrent topics in Margot Zevon's work include Nanoplatforms for cancer theranostics (6 papers), Nanoparticle-Based Drug Delivery (2 papers) and Optical Imaging and Spectroscopy Techniques (2 papers). Margot Zevon is often cited by papers focused on Nanoplatforms for cancer theranostics (6 papers), Nanoparticle-Based Drug Delivery (2 papers) and Optical Imaging and Spectroscopy Techniques (2 papers). Margot Zevon collaborates with scholars based in United States, Singapore and Puerto Rico. Margot Zevon's co-authors include Prabhas V. Moghe, Charles M. Roth, Richard E. Riman, Mei Chee Tan, Dominik J. Naczynski, B. Wall, Jesse Kohl, Vidya Ganapathy, Derek Adler and Mark C. Pierce and has published in prestigious journals such as Nature Communications, Cancer Research and Small.

In The Last Decade

Margot Zevon

8 papers receiving 866 citations

Hit Papers

Rare-earth-doped biological composites as in vivo shortwa... 2013 2026 2017 2021 2013 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Margot Zevon United States 6 629 559 114 109 107 8 871
Zhenluan Xue China 18 687 1.1× 799 1.4× 145 1.3× 100 0.9× 96 0.9× 20 1.0k
Yulai Liu China 5 443 0.7× 378 0.7× 67 0.6× 62 0.6× 87 0.8× 5 610
Shahram Hejazi United States 5 357 0.6× 374 0.7× 100 0.9× 71 0.7× 113 1.1× 8 696
Jesse Kohl United States 6 517 0.8× 538 1.0× 147 1.3× 31 0.3× 67 0.6× 7 766
Dominik J. Naczynski United States 11 741 1.2× 708 1.3× 137 1.2× 90 0.8× 159 1.5× 13 1.1k
Yi‐Hsin Chien Taiwan 14 499 0.8× 526 0.9× 159 1.4× 148 1.4× 176 1.6× 28 904
Barbara Błasiak Poland 15 312 0.5× 499 0.9× 99 0.9× 218 2.0× 55 0.5× 36 829
Liuen Liang Australia 11 378 0.6× 426 0.8× 88 0.8× 80 0.7× 135 1.3× 20 692
Anne-Charlotte Faure France 8 318 0.5× 573 1.0× 51 0.4× 229 2.1× 113 1.1× 11 787

Countries citing papers authored by Margot Zevon

Since Specialization
Citations

This map shows the geographic impact of Margot Zevon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margot Zevon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margot Zevon more than expected).

Fields of papers citing papers by Margot Zevon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margot Zevon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margot Zevon. The network helps show where Margot Zevon may publish in the future.

Co-authorship network of co-authors of Margot Zevon

This figure shows the co-authorship network connecting the top 25 collaborators of Margot Zevon. A scholar is included among the top collaborators of Margot Zevon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margot Zevon. Margot Zevon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Zevon, Margot, Xinyu Zhao, Sheng Yang, et al.. (2017). Surveillance nanotechnology for multi-organ cancer metastases. Nature Biomedical Engineering. 1(12). 993–1003. 52 indexed citations
2.
Zevon, Margot, Vidya Ganapathy, Paul Kim, et al.. (2015). CXCR‐4 Targeted, Short Wave Infrared (SWIR) Emitting Nanoprobes for Enhanced Deep Tissue Imaging and Micrometastatic Cancer Lesion Detection. Small. 11(47). 6347–6357. 46 indexed citations
3.
Zevon, Margot, Vidya Ganapathy, Paul Kim, et al.. (2015). Abstract 1482: Early detection and longitudinal imaging of breast cancer metastatic microlesions using short-wave infrared light emitting rare-earth nanoprobes. Cancer Research. 75(15_Supplement). 1482–1482. 1 indexed citations
4.
Ganapathy, Vidya, Margot Zevon, Richard E. Riman, et al.. (2015). Small animal imaging platform for quantitative assessment of short-wave infrared-emitting contrast agents. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 9311. 93110T–93110T. 1 indexed citations
5.
Zevon, Margot, Vidya Ganapathy, Yang Sheng, et al.. (2015). Line-scanning confocal microscopy for high-resolution imaging of upconverting rare-earth-based contrast agents. Journal of Biomedical Optics. 20(11). 110506–110506. 10 indexed citations
6.
Pinkerton, Nathalie M., Marian E. Gindy, Theodore S. Wolfson, et al.. (2015). Single‐Step Assembly of Multimodal Imaging Nanocarriers: MRI and Long‐Wavelength Fluorescence Imaging. Advanced Healthcare Materials. 4(9). 1376–1385. 58 indexed citations
7.
Naczynski, Dominik J., Mei Chee Tan, Margot Zevon, et al.. (2013). Rare-earth-doped biological composites as in vivo shortwave infrared reporters. Nature Communications. 4(1). 2199–2199. 653 indexed citations breakdown →
8.
Naczynski, Dominik J., Margot Zevon, Larisa Sheihet, et al.. (2013). Multifunctional Albumin Nanoparticles As Combination Drug Carriers for Intra‐Tumoral Chemotherapy. Advanced Healthcare Materials. 2(9). 1236–1245. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026